BDO achieves top rankings in transaction advisory

BDO achieves top rankings in transaction advisory

The breadth of the top rankings for both Germany and internationally shows that BDO is very well positioned in transaction advisory.


"The very good placements in the league tables are proof of BDO's strong growth course and show that we are clearly one of the market leaders in transaction advisory. Behind this is a team of highly qualified colleagues who once again did an excellent job in a very competitive environment last year and successfully established our holistic advisory approach to transactions," says Parwäz Rafiqpoor, member of the executive board of BDO AG Wirtschaftsprüfungsgesellschaft.

Globally, the focus of the completed transactions was on the healthcare, financial services, consumer and real estate sectors. Nationally, BDO was able to demonstrate its expertise particularly in the industry and technology and media sectors. For example, BDO advised MAMBU, one of Germany's largest fintechs, on the $135 million Series D financing led by TCV, or advised on the expansion of the partnership between RheinEnergie and the E.ON subsidiary Westenergie.

At BDO, around 2,500 experts are active worldwide in the field of corporate finance and advise on transactions with a proven holistic approach.

BDO Germany on a strong growth course

BDO Germany has been on a strong growth course for years. In the reporting year 2019/2020, the German BDO Group achieved an increase in revenue of 8.6 per cent to €285 (262) million compared to the previous year - an above-average growth compared to the industry. This reflects the strong demand for BDO expertise despite negative pandemic influences on the economy. In the recent past, BDO had been able to win well-known companies in tenders in the audit of financial statements. In addition to the Dax group SAP, these include, for example, the food group Theo Müller, in the financial sector Citigroup Global Markets Europe AG and MLP as well as in consulting the vaccine manufacturer BionTech.